Back to ARROWSTREET CAPITAL, LIMITED PARTNERSHIP ARROWSTREET CAPITAL, LIMITED PARTNERSHIP

STLNSTLN
3 quarters

Position history for ARROWSTREET CAPITAL, LIMITED PARTNERSHIPARROWSTREET CAPITAL, LIMITED PARTNERSHIP's holdings in Starling Oncology, Inc.

ARROWSTREET CAPITAL, LIMITED PARTNERSHIP holds 710,888 shares of STLN (Starling Oncology, Inc.), worth $3.9M as of 2026-Q2. The position was increased (+69.5% shares). STLN represents 0.0% of ARROWSTREET CAPITAL, LIMITED PARTNERSHIP's portfolio.

Current Value

$3.9M

Current Shares

710,888

Total Value Change

+$3.3M

Total Shares Change

+555,164

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
710,888
+69.5%
$3.9M0.0%$5.43
40
2026-Q1
Increased
419,423
+169.3%
$1.3M0.0%$3.07
41
2025-Q4
New
155,724
-
$554,3770.0%$3.56
34

Other major holders of STLN: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used